Briodine 2 % Solution is a Health Canada–registered veterinary drug (DIN 01981404) held by Central Sales Limited, containing Iodine. Health Canada lists its status as Cancelled Post Market (status date 25 Oct 2018). Nexara Health has matched 77 registrations of Iodine across 12 other regulated markets.
Health Canada registration
| DIN | 01981404 |
|---|---|
| Brand name | Briodine |
| Active ingredient | Iodine |
| Strength | 2 % |
| Dosage form | Solution |
| Route | Subcutaneous |
| Company | Central Sales Limited |
| Status | Cancelled Post Market — 25 Oct 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Iodine registered in other markets
77 registrations of the same molecule in 12 national registries outside Canada (first 57 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Iodine | — | EP | PBS | ||
| Bulgaria | Alcocholic iodine solutio - Flo | "Флора - 02" ООД | 5% cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Alcocholic iodine solution 5% | "Тони-М" ООД | cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Solutio iodi spirituosa Chemax Pharma | Химакс Фарма ЕООД | 5% cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Solutio Iodi spirituosa Galen-Pharma | Гален Фарма ООД | 5% cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Solutio iodi spirituosa VT | Софарма Ад | 5% cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Solutio Rivanoli Kupro | Купро ЕООД | 0.1% cutaneous solution | дермален разтвор | Без лекарско предписание | BDA |
| Bulgaria | Solution Iodi Spirituosa Kupro | Купро ЕООД, | 5% cutanеous solution | разтвор за приложение въру кожата | Без лекарско предписание | BDA |
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 50 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 100 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 200 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 50 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 100 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 200 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 40% W/V BOTTLE x 100 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Greece | IOMERON INJ.SOL 40% W/V BOTTLE x 200 ML | Bracco Imaging Spa, 20134-Milano, Italy | reimbursed | MoH deltio timwn | ||
| Hong Kong | Nodonool Ex Cool Sore Throat Spray 0.5% W/V | Kobayashi Pharmaceutical (Hong Kong) Company Limited | Registered | DH Drug Office | ||
| Hong Kong | Nodonool Sore Throat Spray | Kobayashi Pharmaceutical (Hong Kong) Company Limited | Registered | DH Drug Office | ||
| Malaysia | Biospray 1% Solution | Range Pharma Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Lipiodol Ultra Fluide 10ml | Medi-Diagnostic Solutions (M) Sdn. Bhd. | New Chemical Entity | PRODUCT APPROVED | NPRA | |
| Malta | YODAFAR 200 micrograms tablets | NeoFarma Pharmaceuticals Limited | Tablet | Authorised | Medicines Authority | |
| Malta | YODAFAR 200 micrograms Tablets | Bial - Portela & C S.A. | Tablet | Authorised | Medicines Authority | |
| Malta | YODAFAR 300 micrograms Tablets | Bial - Portela & C S.A. | Tablet | Authorised | Medicines Authority | |
| Poland | Blockade | Delaval NV | 2,56 mg/ml | Roztwór do kąpieli strzyków | Bezterminowe | URPL RPL |
| Poland | Proactive | DeLaval n.v. | 1,52 mg/ml | Roztwór na strzyki, kąpiel / aerozol | Bezterminowe | URPL RPL |
| South Africa | Scanlux 300mg/ml | Medicine Developers International Healthcare cc | 300 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 300mg/ml | Medicine Developers International Healthcare cc | 300 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 300mg/ml | Medicine Developers International Healthcare cc | 300 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 300mg/ml | Medicine Developers International Healthcare cc | 300 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 370mg/ml | Medicine Developers International Healthcare cc | 370 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 370mg/ml | Medicine Developers International Healthcare cc | 370 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 370mg/ml | Medicine Developers International Healthcare cc | 370 mg/ml | Inj | S4 | DoH SEP database |
| South Africa | Scanlux 370mg/ml | Medicine Developers International Healthcare cc | 370 mg/ml | Inj | S4 | DoH SEP database |
| Taiwan | Iodine Resublimed "E. Merck" | MERCK KGaA | （粉） | 已註銷 | TFDA | |
| Taiwan | Iodine Resublimed "E.merck" | MERCK KGaA | （粉） | 已註銷 | TFDA | |
| Taiwan | Iodine Resublimed "E.merck" | MERCK KGaA | （粉） | 已註銷 | TFDA | |
| Taiwan | Iodine Tincture "C.m." | 中美兄弟製藥股份有限公司 | 酊劑 | Registered | TFDA | |
| Taiwan | Iodine-131 Oral Solution "Iner" | 國家原子能科技研究院核醫製藥中心 | 口服液劑 | 已註銷 | TFDA | |
| Taiwan | Iodium Ch.p.ii "K.y." | 洸洋化學製藥股份有限公司 | 原料藥結晶性粉末 | 已註銷 | TFDA | |
| Taiwan | Iodum "Hoei" | Hoei Pharmaceutical Co. Ltd. | 原料藥結晶性粉末 | 已註銷 | TFDA | |
| Taiwan | Iodum "Hoei" | Hoei Pharmaceutical Co. Ltd. | （粉） | 已註銷 | TFDA | |
| United Arab Emirates | Iodosorb Dressing | Perstorp Speciality Chemicals AB, Sweden, Perstorp | N/A | Dressing | Active | EDE |
| United Arab Emirates | Iodosorb Dressing | Perstorp Speciality Chemicals AB, Sweden, Perstorp | N/A | Dressing | Active | EDE |
| United Arab Emirates | Iodosorb Dressing | Perstorp Speciality Chemicals AB, Sweden, Perstorp | N/A | Dressing | Active | EDE |
| United Arab Emirates | Iodosorb Dressing | Perstorp Speciality Chemicals AB, Sweden, Perstorp | N/A | Dressing | Active | EDE |
| United Kingdom | Iodine 1% aqueous topical solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Iodine 1% in Boric acid ear powder | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Iodine 1% in Industrial methylated spirit 70% solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Iodine 2% in Industrial methylated spirit 70% solution | — | 0001 | NHS dm+d VMP | ||
| United States | Ioddo Iodine | Evi Labs | Tincture | listed | FDA NDC | |
| United States | Iodine | Nice-Pak Products, LLC | Liquid | listed | FDA NDC | |
| United States | Iodine | Walgreen Co. | Liquid | listed | FDA NDC | |
| United States | Iodine | United Natural Foods, Inc. dba UNFI | Liquid | listed | FDA NDC | |
| United States | Iodine Tincture (IODO) First Aid Antiseptic | Germa Products, LLC | Liquid | listed | FDA NDC | |
| United States | Iodium | Boiron | Pellet | listed | FDA NDC | |
| United States | Iodium | Boiron | Pellet | listed | FDA NDC | |
| United States | Iodium | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Iodine worldwide →
Regulator price references for Iodine
Published list or reimbursement prices for Iodine presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Greece | OMNIPAQUE INJ.SOL 64,7% (30)% BTx1 BOTTLE x 50ML (PLASTIC BOTTLE P.P) (PLASTIC BOTTLE P.P) | 50ml+64.7pct | 7.43 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | OMNIPAQUE INJ.SOL 75,5% (35)% BTx1BOTTLEx50ML (PLASTIC BOTTLE P.P) (PLASTIC BOTTLE P.P) | 50ml+75.5pct | 9.46 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 50 ML | 30pct+50ml | 13.12 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOPAMIRO SOL.OR/REC 61,24%(30%IODINE) FLx20ML(ΓΥΑΛ.ΦΙΑΛ.) | 20ml+61.24pct | 13.23 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | OMNIPAQUE INJ.SOL 64,7% (30)% BTx1 BOTTLEx100ML (PLASTIC BOTTLE P.P) (PLASTIC BOTTLE P.P) | 100ml+64.7pct | 14.88 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 50 ML | 35pct+50ml | 16.87 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | OMNIPAQUE INJ.SOL 75,5% (35)% BTx1BOTTLEx100ML (PLASTIC BOTTLE P.P) (PLASTIC BOTTLE P.P) | 100ml+75.5pct | 17.42 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 100 ML | 100ml+30pct | 25.58 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 100 ML | 100ml+35pct | 30.28 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOPAMIRO SOL.OR/REC 61,24%(30%IODINE) FLx50ML(ΓΥΑΛ.ΦΙΑΛ.) | 50ml+61.24pct | 34.12 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 40% W/V BOTTLE x 100 ML | 100ml+40pct | 34.22 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 30% W/V BOTTLE x 200 ML | 200ml+30pct | 52.45 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 35% W/V BOTTLE x 200 ML | 200ml+35pct | 58.54 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Greece | IOMERON INJ.SOL 40% W/V BOTTLE x 200 ML | 200ml+40pct | 66.89 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| South Africa | Scanlux 300mg/ml | 300mg/1ml | 50 | 258.71 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 370mg/ml | 370mg/1ml | 50 | 348.66 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 300mg/ml | 300mg/1ml | 100 | 517.43 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 370mg/ml | 370mg/1ml | 100 | 697.32 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 300mg/ml | 300mg/1ml | 200 | 1,034.86 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 370mg/ml | 370mg/1ml | 200 | 1,394.63 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 300mg/ml | 300mg/1ml | 500 | 2,587.16 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Scanlux 370mg/ml | 370mg/1ml | 500 | 3,486.56 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Briodine (DIN 01981404) marketed in Canada?
No. Health Canada lists DIN 01981404 as Cancelled Post Market as of 25 Oct 2018.
Who holds the Canadian licence for this product?
Central Sales Limited is the company of record in the Health Canada Drug Product Database.
Is Iodine registered outside Canada?
Yes — Nexara Health has matched 77 registrations in 12 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 01981404, status date 2018-10-25; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, NPRA, PBS, TFDA, URPL RPL; price sources: DoH SEP database, MoH deltio timwn. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 01981404, status date 2018-10-25; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, NPRA, PBS, TFDA, URPL RPL; price sources: DoH SEP database, MoH deltio timwn.
Health Canada Drug Product Database (DPD), DIN 01981404, status date 2018-10-25; national medicine registries: BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, Medicines Authority, MoH deltio timwn, NHS dm+d VMP, NPRA, PBS, TFDA, URPL RPL; price sources: DoH SEP database, MoH deltio timwn. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.